Downregulation of HTATIP2/TIP30 has also been observed in other cancer types, including melanoma, colon cancer, breast cancer, neuroblastoma, and hepatocellular carcinoma [13,14,16]. The gene discussed is HTATIP2; the disease is neuroblastoma.